KELLIE TOLIN: Open Payments
NPI 1851373765 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$21,207 in 137 payments from 15 companies in 2025. Trend: 2023 $3,089 · 2024 $2,123 · 2025 $21,207
Speaker / faculty: $16,610Food & beverage: $2,702Travel & lodging: $1,894
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 36 | $19,289 |
| ABBVIE INC. | 15 | $298 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $257 |
| Otsuka America Pharmaceutical, Inc. | 12 | $246 |
| Bausch Health US, LLC | 12 | $189 |
| Noven Therapeutics, LLC | 12 | $163 |
| Teva Pharmaceuticals USA, Inc. | 9 | $150 |
| Neurocrine BioSciences, Inc. | 7 | $148 |
| Axsome Therapeutics, Inc. | 9 | $143 |
| Vanda Pharmaceuticals Inc. | 6 | $98 |
Products named: SPRAVATO, REXULTI, VRAYLAR, CAPLYTA, Xelstrym, INGREZZA, Auvelity, WELLBUTRIN.
Industry payments across NC — which companies pay providers there.
